Technology Transfer

Case Western Reserve University's Technology Transfer Office (TTO) serves our innovators with full-spectrum intellectual property services. For both faculty and students, we provide support for intellectual property and commercialization that spans the research & development continuum. We serve our researchers by assessing and building upon the commercial potential of new ideas and inventions.

Through interaction with our inventors, regional and national networks, including our affiliate healthcare systems, and potential commercial partners, we endeavor to determine the best path of translation and ultimate commercialization for University intellectual assets.

Consistent with the University's mission, the Technology Transfer Office is working towards enhancing its role in the promotion of an inclusive culture of global citizenship by exploring issues of access to essential medicines by resource-limited countries. This work includes moving towards the Universities Allied for Essential Medicine's Global Access Licensing Framework

Recent News

NervGen Pharma Completes $10 Million Initial Public Offering; Shares to Commence Trading on TSX-V on March 15, 2019 – Symbol “NGEN”

--Investing News Network March 13, 219

CWRU Receives Third-Straight $500,000 Technology Startup Fund Award from Ohio Third Frontier Commission

-- CWRU Daily January 16, 2019

PAVmed Subsidiary Lucid Diagnostics Files 510(k) Submission with FDA for EsoCheck Cell Collection Device

-- GlobeNewswire November 29, 2018


For Questions About...

  • Your Invention Disclosure Form (IDF), please contact Joy Chen at 216.368.0362.
  • A Material Transfer Agreement (MTA) that needs to be approved and signed, please complete our ‌MTA Review Form (required for all MTAs) and send the completed form, along with an electronic copy of the incoming MTA to Kristopher Kramp.
  • Sending materials or samples to another institution? For your outgoing Material Transfer Agreement (MTA), please contact Kristopher Kramp at 216.368.2026.
  • CWRU's High-Throughput Screening services, please contact Stephanie Weidenbecher at 216.368.6191.
  • Anything else, please contact Daniel Pendergast at 216.368.0184.